Using lightweight reinforced concrete beams with glass fiber bars (GFRP) is one approach for achieving the requirement seismic design idea of “strong-columns weak-beams”. Twelve full-scale normal-strength concrete (NC with fc` = 32 MPa) and high-strength lightweight concrete (HSLWC with fc` = 42, 49 and 52 MPa) exterior beam-column joints have been tested under cyclic loadings. The beams were reinforced with conventional steel bars (CS) and GFRP using steel fibers (SF). The experimental joint shear force was compared with that estimated by some international codes such as the American Concrete Institute (ACI-19), the Egyptian code (ECP-07), and the New Zealand Code (NZS-06). Nonlinear finite element analysis (ABAQUS) was carried out. In the present study, three main parameters were explored (1) HSLWC, (2) GFRP ratios equal to 0.70%, 1.03% and 1.37%, (3) SF ratios equal to 0.0%, 0.75% and 1.50%. The findings of the experiment revealed that increasing the concrete strength from NC with conventional steel bars to high-strength lightweight concrete HSLWC (fc` = 42 MPa) with the same ratio of GFRP bars enhanced the first cracking load by about 25%. Increasing the SF ratio to 1.50% enhanced the failure load by 18–24% when compared with non-fiber specimens. The predicted joint shear strength estimated using the equations of the ACI 318-19 and ECP-07 are conservative for HSLWC exterior beam-column connection reinforced with GFRP bars but the predicted joint shear strength by using the equations of the NZS-07 is on the borderline for some cases. The finite element program ABAQUS can be used successfully to forecast the behavior of HSLWC beam-column connections reinforced with GFRP under seismic loadings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.